Literature DB >> 15593196

NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.

Shaochun Bai1, Hongtao Liu, Kun-Hung Chen, Polikseni Eksarko, Harris Perlman, Terry L Moore, Richard M Pope.   

Abstract

OBJECTIVE: Little apoptosis has been observed in rheumatoid arthritis (RA) synovial tissues. Tumor necrosis factor alpha (TNFalpha) is expressed in the joints of patients with RA, yet RA synovial fibroblasts are relatively resistant to apoptosis induced by TNFalpha. Recently, we demonstrated that FLIP is highly expressed in the RA joint. These studies were performed to determine if TNFalpha-induced NF-kappaB controls the expression of FLIP long (FLIP(L)) and FLIP short (FLIP(S)) in RA synovial fibroblasts and to determine the role of FLIP in the control of TNFalpha-induced apoptosis.
METHODS: RA synovial fibroblasts were isolated from RA synovial tissues and used between passages 3 and 9. RA synovial or control fibroblasts were sham infected or infected with a control adenovirus vector or one expressing the super-repressor IkappaBalpha (srIkappaBalpha). The cells were stimulated with TNFalpha or a control vehicle, and expression of FLIP(L) and FLIP(S) was determined by isoform-specific real-time polymerase chain reaction and Western blot analysis. Cell viability was determined by XTT cleavage, and apoptosis was determined by annexin V staining, DNA fragmentation, and activation of caspases 8 and 3.
RESULTS: TNFalpha induced the expression of both isoforms of FLIP messenger RNA (mRNA) in RA synovial fibroblasts; however, FLIP(L) was the dominant isoform detected by Western blot analysis. In control fibroblasts, TNFalpha induced the expression of FLIP(L) and FLIP(S) mRNA and protein. The TNFalpha-induced, but not the basal, expression of FLIP was regulated by NF-kappaB. When NF-kappaB activation was suppressed by the expression of srIkappaBalpha, TNFalpha-mediated apoptosis was induced. TNFalpha-induced apoptotic cell death was mediated by caspase 8 activation and was prevented by the ectopic expression of FLIP(L) or the caspase 8 inhibitor CrmA.
CONCLUSION: The TNFalpha-induced, but not the basal, expression of FLIP is regulated by NF-kappaB in RA synovial fibroblasts. The resistance of RA synovial fibroblasts to TNFalpha-induced apoptosis is mediated by the NF-kappaB-regulated expression of FLIP. These observations support the role of NF-kappaB and FLIP as attractive therapeutic targets in RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15593196     DOI: 10.1002/art.20680

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway.

Authors:  Luting Xu; Li Zhang; Anne M Bertucci; Richard M Pope; Syamal K Datta
Journal:  Immunol Lett       Date:  2008-09-21       Impact factor: 3.685

2.  Bufalin exerts inhibitory effects on IL-1β-mediated proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Yue-wen Chang; Yong-fang Zhao; Yue-long Cao; Wei Gu; Jian Pang; Hong-sheng Zhan
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

3.  JAB1 determines the response of rheumatoid arthritis synovial fibroblasts to tumor necrosis factor-alpha.

Authors:  Jianhua Wang; Chuanyu Li; Yuelong Liu; Wan Mei; Shaohua Yu; Cunren Liu; Liming Zhang; Xu Cao; Robert P Kimberly; William Grizzle; Huang-Ge Zhang
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

4.  Fas ligand deficiency impairs host inflammatory response against infection with the spirochete Borrelia burgdorferi.

Authors:  Cuixia Shi; Julie Wolfe; Jennifer Q Russell; Karen Fortner; Nicholas Hardin; Juan Anguita; Ralph C Budd
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  Flice inhibitory protein is associated with the survival of neonatal neutrophils.

Authors:  Ramachandran Rashmi; Patricia M Schnulle; Allison C Maddox; Eric S Armbrecht; Joyce M Koenig
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

Review 6.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

7.  Akt activity protects rheumatoid synovial fibroblasts from Fas-induced apoptosis by inhibition of Bid cleavage.

Authors:  Samuel García; Myriam Liz; Juan J Gómez-Reino; Carmen Conde
Journal:  Arthritis Res Ther       Date:  2010-02-26       Impact factor: 5.156

Review 8.  Intracellular apoptotic pathways: a potential target for reducing joint damage in rheumatoid arthritis.

Authors:  Bonnie Williams; Anak Dharmapatni; Tania Crotti
Journal:  Inflamm Res       Date:  2017-11-21       Impact factor: 4.575

9.  Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha-induced apoptosis.

Authors:  Salahuddin Ahmed; Matthew D Silverman; Hubert Marotte; Kevin Kwan; Natalie Matuszczak; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2009-05

10.  Dual knockdown of p65 and p50 subunits of NF-kappaB by siRNA inhibits the induction of inflammatory cytokines and significantly enhance apoptosis in human primary synoviocytes treated with tumor necrosis factor-alpha.

Authors:  Ui Jin Lee; So-Rim Choung; K V Bhanu Prakash; Eun-Ju Lee; Mi Young Lee; Young Joo Kim; Chang-Whan Han; Young-Chul Choi
Journal:  Mol Biol Rep       Date:  2007-05-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.